← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $372K of Replimune Group, Inc.

Sold$372,186
$20.01Price
18,600Shares
−7%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, Aug 22. Filed Thu, Aug 24, 4:30 PM ET, after the close. Not investment advice.